A. V. D. Van Der Zee

发表

Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer

R. Bast, E. Fung, D. Chan, 2004, Cancer Research.

H. Hollema, A. V. D. Van Der Zee, E. D. de Vries, 2009, PLoS medicine.

Proteomic alterations in early stage cervical cancer

H. Hollema, A. V. D. Van Der Zee, V. Guryev, 2018, Oncotarget.

The effect of pre-existing immunity on the capacity of influenza virosomes to induce cytotoxic T lymphocyte activity.

A. V. D. Van Der Zee, J. Wilschut, A. de Mare, 2008, Vaccine.

Profiling studies in ovarian cancer: a review.

A. V. D. Van Der Zee, E. D. de Vries, A. Crijns, 2007, The oncologist.

Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma.

D. Katsaros, G. Yousef, A. Scorilas, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sample preparation of human serum for the analysis of tumor markers. Comparison of different approaches for albumin and gamma-globulin depletion.

H. D. de Bruijn, A. V. D. Van Der Zee, S. de Jong, 2003, Journal of chromatography. A.

Evidence Based Selection of Housekeeping Genes

W. Kamps, A. V. D. Van Der Zee, E. D. de Vries, 2007, PloS one.

HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

Brooke L. Fridley, Hugo M. Horlings, Andrew E. Teschendorff, 2015, Genome Medicine.

HLA genes and other candidate genes involved in susceptibility for (pre)neoplastic cervical disease.

A. V. D. Van Der Zee, E. D. de Vries, G. T. te Meerman, 2005, International journal of oncology.

Distinguishing benign and malignant pelvic masses: the value of different diagnostic methods in everyday clinical practice.

A. V. D. Van Der Zee, W. Sluiter, P. Willemse, 2008, European journal of obstetrics, gynecology, and reproductive biology.

Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy

A. V. D. Van Der Zee, E. D. de Vries, P. Willemse, 2002, British Journal of Cancer.

TAMOXIFEN TREATMENT AND GYNECOLOGIC SIDE EFFECTS: A REVIEW

H. Hollema, A. V. D. Van Der Zee, E. de Vries, 2001, Obstetrics and gynecology.

Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways

A. V. D. Van Der Zee, S. de Jong, G. Meersma, 2016, Genome Medicine.

Telomerase in relation to expression of p53, c-Myc and estrogen receptor in ovarian tumours.

H. Hollema, A. V. D. Van Der Zee, E. D. de Vries, 2003, International journal of oncology.

Abnormal velocity waveforms of the umbilical artery in growth retarded fetuses: relationship to antepartum late heart rate decelerations and outcome.

G. Visser, A. V. D. Van Der Zee, D. J. Bekedam, 1990, Early human development.

DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women

E. Schuuring, A. V. D. Van Der Zee, W. Melchers, 2014, British Journal of Cancer.

Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva.

P. V. van Diest, A. V. D. Van Der Zee, R. Verheijen, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gynecologic screening in hereditary nonpolyposis colorectal cancer.

H. Hollema, A. V. D. Van Der Zee, J. Kleibeuker, 2003, Gynecologic oncology.

Death receptors and ligands in cervical carcinogenesis: an immunohistochemical study.

H. Boezen, H. Hollema, A. V. D. Van Der Zee, 2005, Gynecologic oncology.

Surgery and radiotherapy in vulvar cancer.

A. V. D. Van Der Zee, J. D. de Hullu, A. V. D. van der Zee, 2006, Critical reviews in oncology/hematology.

Quantitative and qualitative aspects of topoisomerase I and II alpha and beta in untreated and platinum/cyclophosphamide treated malignant ovarian tumors.

H. Hollema, A. V. D. Van Der Zee, E. D. de Vries, 1994, Cancer research.

The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium.

A. V. D. Van Der Zee, E. D. de Vries, P. Willemse, 2002, Journal of clinical pathology.

Apoptosis and apoptosis-associated parameters in relation to tamoxifen exposure in postmenopausal endometrium.

H. Hollema, A. V. D. Van Der Zee, E. D. de Vries, 2002, Human pathology.

Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen.

A. V. D. Van Der Zee, E. D. de Vries, P. Willemse, 1999, Gynecologic oncology.

Zoning of mucosal phenotype, dysplasia, and telomerase activity measured by telomerase repeat assay protocol in Barrett's esophagus.

A. V. D. Van Der Zee, L. Neilson, W. Keith, 2004, Neoplasia.

Update on the sentinel lymph node procedure in vulvar cancer

A. V. D. Van Der Zee, J. D. de Hullu, H. P. van de Nieuwenhof, 2010, Expert review of anticancer therapy.

The role of sentinel node biopsy in gynecological cancer: a review

A. V. D. Van Der Zee, J. D. de Hullu, H. P. van de Nieuwenhof, 2009, Current opinion in oncology.

A biological question and a balanced (orthogonal) design: the ingredients to efficiently analyze two-color microarrays with Confirmatory Factor Analysis

A. V. D. Van Der Zee, E. D. de Vries, A. Crijns, 2006, BMC Genomics.

Genome-wide promoter analysis uncovers portions of the cancer methylome.

E. Schuuring, A. V. D. Van Der Zee, J. Califano, 2008, Cancer research.

Phase II study of intraperitoneal cisplatin plus systemic etoposide as second-line treatment in patients with small volume residual ovarian cancer.

A. V. D. Van Der Zee, N. Mulder, E. de Vries, 1995, European journal of cancer.

Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: A systematic review.

H. Hollema, A. V. D. Van Der Zee, G. D. de Bock, 2017, Gynecologic oncology.

Lymphvascular space involvement: an independent prognostic factor in endometrial cancer.

H. Boezen, H. Hollema, A. V. D. Van Der Zee, 2005, Gynecologic oncology.

Presentations of endometrial activity after curative radiotherapy for cervical cancer.

H. Hollema, A. V. D. Van Der Zee, J. D. de Hullu, 2005, Maturitas.

Identification of genes and pathways associated with cytotoxic T lymphocyte infiltration of serous ovarian cancer

H. Boezen, H. Hollema, A. V. D. Van Der Zee, 2010, British Journal of Cancer.

The extrinsic apoptosis pathway and its prognostic impact in ovarian cancer.

H. Hollema, A. V. D. Van Der Zee, E. D. de Vries, 2010, Gynecologic oncology.

Repeat sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma is feasible.

A. V. D. Van Der Zee, H. V. van Doorn, K. Gaarenstroom, 2016, Gynecologic oncology.

Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study.

H. Hollema, A. V. D. Van Der Zee, R. Verheijen, 2010, The Lancet. Oncology.

Sentinel lymph node biopsy in patients with gynecologic cancers Expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008.

A. V. D. Van Der Zee, A. Schneider, R. Coleman, 2009, Gynecologic oncology.

Multimodality treatment warranted for ovarian cancer: immunotherapy, a prerequisite to improve prognosis for this vicious disease.

A. V. D. Van Der Zee, T. Daemen, N. Leffers, 2009, Immunotherapy.

P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide chemotherapy.

H. Hollema, A. V. D. Van Der Zee, E. D. de Vries, 1991, Cancer research.

Functional validation of putative tumor suppressor gene C13ORF18 in cervical cancer by Artificial Transcription Factors

M. Rots, E. Schuuring, A. V. D. Van Der Zee, 2013, Molecular oncology.

Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.

A. V. D. Van Der Zee, E. D. de Vries, S. de Jong, 2008, International journal of radiation oncology, biology, physics.

Telomerase in relation to clinicopathologic prognostic factors and survival in cervical cancer

H. Hollema, A. V. D. Van Der Zee, E. D. de Vries, 2001, International journal of cancer.

Sulindac treatment in hereditary non-polyposis colorectal cancer.

H. Hollema, A. V. D. Van Der Zee, T. van der Sluis, 2007, European journal of cancer.

Genome-wide methylome analysis using MethylCap-seq uncovers 4 hypermethylated markers with high sensitivity for both adeno- and squamous-cell cervical carcinoma

E. Schuuring, A. V. D. Van Der Zee, H. Klip, 2016, Oncotarget.

Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer

H. Hollema, A. V. D. Van Der Zee, E. D. de Vries, 2006, Gut.

Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages.

H. Hollema, A. Zee, A. V. D. Van Der Zee, 2001, Cancer research.

Multidimensional separation of tryptic peptides from human serum proteins using reversed-phase, strong cation exchange, weak anion exchange, and fused-core fluorinated stationary phases.

A. V. D. Van Der Zee, R. Bischoff, N. Govorukhina, 2013, Journal of separation science.

Heterologous prime-boost immunizations with a virosomal and an alphavirus replicon vaccine.

A. V. D. Van Der Zee, P. Jansen-Dürr, J. Wilschut, 2011, Molecular pharmaceutics.

Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy.

H. Hollema, A. V. D. Van Der Zee, E. D. de Vries, 1992, British Journal of Cancer.

Aromatase in the context of breast and endometrial cancer. A review.

H. Hollema, A. V. D. Van Der Zee, M. Heineman, 2006, Minerva endocrinologica.

Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma.

M. Kool, D. Katsaros, H. Arts, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Biobanking of patient and patient-derived xenograft ovarian tumour tissue: efficient preservation with low and high fetal calf serum based methods

A. V. D. Van Der Zee, S. de Jong, G. Meersma, 2015, Scientific Reports.

The prognostic value of TRAIL and its death receptors in cervical cancer.

H. Hollema, A. V. D. Van Der Zee, E. D. de Vries, 2009, International journal of radiation oncology, biology, physics.

Prediction of lymph node metastases in vulvar cancer: a review.

H. Hollema, A. V. D. Van Der Zee, J. D. de Hullu, 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

A robust ex vivo model for evaluation of induction of apoptosis by rhTRAIL in combination with proteasome inhibitor MG132 in human premalignant cervical explants

H. Hollema, A. V. D. Van Der Zee, E. D. de Vries, 2008, International journal of cancer.

Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.

H. Hollema, H. D. de Bruijn, A. V. D. Van Der Zee, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

P53‐specific T cell responses in patients with malignant and benign ovarian tumors: Implications for p53 based immunotherapy

S. H. van der Burg, H. Hollema, R. Offringa, 2007, International journal of cancer.

Expression of macrophage colony-stimulating factor (M-CSF), interleukin-6, (IL-6), interleukin-1 beta (IL-1 beta), interleukin-11 (IL-11) and tumour necrosis factor-alpha (TNF-alpha) in p53-characterised human ovarian carcinomas.

H. Hollema, A. V. D. Van Der Zee, E. D. de Vries, 1997, European journal of cancer.

Less Gastrointestinal Toxicity After Adjuvant Radiotherapy on a Small Pelvic Field Compared to a Standard Pelvic Field in Patients With Endometrial Carcinoma

H. Boezen, H. Hollema, A. V. D. Van Der Zee, 2012, International Journal of Gynecologic Cancer.

Laparoscopic placement of PAP catheters for intraperitoneal chemotherapy in ovarian carcinoma.

H. Arts, A. V. D. Van Der Zee, E. D. de Vries, 1998, Gynecologic Oncology.

Update on sentinel lymph node biopsy for early-stage vulvar cancer.

A. V. D. Van Der Zee, R. Coleman, B. Slomovitz, 2015, Gynecologic oncology.

Modern management of vulvar cancer

A. V. D. Van Der Zee, J. D. de Hullu, M. Oonk, 2004, Current opinion in obstetrics & gynecology.

Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.

H. Boezen, H. Hollema, A. V. D. Van Der Zee, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Letter commenting on "Patholologic finding in prophylactic oophorectomy specimens in high-risk women" (87:52-6) by Pamela Paley, et al. (, fax: +31-206-685-9607).

H. Hollema, A. V. D. Van Der Zee, M. Mourits, 2004, Gynecologic Oncology.

Quality of Life and Sexual Functioning After Vulvar Reconstruction With the Lotus Petal Flap

A. V. D. Van Der Zee, G. D. de Bock, P. Werker, 2018, International Journal of Gynecologic Cancer.

Current controversies in the management of patients with early-stage vulvar cancer

A. V. D. Van Der Zee, J. D. de Hullu, M. Oonk, 2010, Current opinion in oncology.

Gynecologic examination and cervical biopsies after (chemo) radiation for cervical cancer to identify patients eligible for salvage surgery.

H. Hollema, A. V. D. Van Der Zee, P. Willemse, 2006, International journal of radiation oncology, biology, physics.

Analysis of the entire HLA region in susceptibility for cervical cancer: a comprehensive study

A. V. D. Van Der Zee, E. D. de Vries, G. T. te Meerman, 2005, Journal of Medical Genetics.

Beware of amenorrhea during tamoxifen: it may be a wolf in sheep's clothing.

A. V. D. Van Der Zee, E. D. de Vries, P. Willemse, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Telomerase activity as a biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smear.

H. Hollema, A. V. D. Van Der Zee, E. D. de Vries, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Noninvasive detection of inguinofemoral lymph node metastases in squamous cell cancer of the vulva by L-

H. Hollema, A. V. D. Van Der Zee, J. Pruim, 1999, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Antagonism of HSV-tk Transfection and Ganciclovir Treatment on Chemotherapeutic Drug Sensitivity

A. V. D. Van Der Zee, W. Vaalburg, N. Mulder, 2005, Journal of chemotherapy.

[The effects of tamoxifen on the female genital tract].

A. V. D. Van Der Zee, E. D. de Vries, P. Willemse, 2003, Nederlands tijdschrift voor geneeskunde.

The value of cancer antigen 125 (CA 125) during treatment and follow-up of patients with ovarian cancer.

H. D. de Bruijn, A. V. D. Van Der Zee, J. Aalders, 1997, Current opinion in obstetrics & gynecology.

Re-expression of Selected Epigenetically Silenced Candidate Tumor Suppressor Genes in Cervical Cancer by TET2-directed Demethylation.

M. Rots, K. Kok, E. Schuuring, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer.

H. Hollema, A. V. D. Van Der Zee, H. Nijman, 2009, Gynecologic oncology.

Aromatase, Cyclooxygenase 2, HER-2/neu, and P53 as Prognostic Factors in Endometrioid Endometrial Cancer

H. Boezen, H. Boezen, H. Hollema, 2009, International Journal of Gynecologic Cancer.

No association of anti-Chlamydia trachomatis antibodies and severity of cervical neoplasia

W. Quint, A. V. D. Van Der Zee, A. Adriaanse, 2001, Sexually transmitted infections.

Serum Tryptophan and Kynurenine Concentrations as Parameters for Indoleamine 2,3-Dioxygenase Activity in Patients With Endometrial, Ovarian, and Vulvar Cancer

H. Boezen, H. Hollema, A. V. D. Van Der Zee, 2011, International Journal of Gynecologic Cancer.

Radical Surgery in Patients With Residual Disease After (Chemo)Radiation for Cervical Cancer

H. Hollema, A. V. D. Van Der Zee, H. Klip, 2014, International Journal of Gynecologic Cancer.

Cell Surface Delivery of TRAIL Strongly Augments the Tumoricidal Activity of T Cells

Baofeng Yang, A. V. D. Van Der Zee, H. Klip, 2011, Clinical Cancer Research.

The prevalence of underlying bleeding disorders in patients with heavy menstrual bleeding with and without gynecologic abnormalities.

A. V. D. Van Der Zee, H. Kluin-Nelemans, K. Meijer, 2013, American journal of obstetrics and gynecology.

Chip‐LC‐MS for label‐free profiling of human serum

Frank Suits, Peter Horvatovich, Rainer Bischoff, 2007, Electrophoresis.

The Clinical Value of Squamous Cell Carcinoma Antigen in Cancer of the Uterine Cervix

H. Hollema, H. D. de Bruijn, A. V. D. Van Der Zee, 1998, Tumor Biology.

Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia

E. Schuuring, A. V. D. Van Der Zee, D. Baarle, 2007, Clinical and experimental immunology.

A panel of regulated proteins in serum from patients with cervical intraepithelial neoplasia and cervical cancer.

A. V. D. Van Der Zee, H. Klip, R. Bischoff, 2014, Journal of proteome research.

Rising serum values of beta-subunit human chorionic gonadotrophin (hCG) in patients with progressive vulvar carcinomas.

H. D. de Bruijn, A. V. D. Van Der Zee, K. T. ten Hoor, 1997, British Journal of Cancer.

Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.

Steven J Skates, Yinhua Yu, R. Bast, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Virosomal Immunization Strategy against Cervical Cancer and Pre-Malignant Cervical Disease

A. V. D. Van Der Zee, J. Wilschut, A. de Mare, 2006, Antiviral therapy.

DNA hypermethylation biomarkers to predict response to cisplatin treatment, radiotherapy or chemoradiation: the present state of art

E. Schuuring, A. V. D. Van Der Zee, S. de Jong, 2012, Cellular Oncology.

ARID1A mutant ovarian clear cell carcinoma: A clear target for synthetic lethal strategies.

A. V. D. Van Der Zee, K. Berns, S. de Jong, 2018, Biochimica et biophysica acta. Reviews on cancer.

Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma

R. Bernards, J. Brenton, A. V. D. Van Der Zee, 2018, Clinical Cancer Research.

Tumor-infiltrating Cytotoxic T Lymphocytes as Independent Prognostic Factor in Epithelial Ovarian Cancer With Wilms Tumor Protein 1 Overexpression

S. H. van der Burg, H. Hollema, A. V. D. Van Der Zee, 2011, Journal of immunotherapy.

Interleukin‐10 and Fas polymorphisms and susceptibility for (pre)neoplastic cervical disease

A. V. D. Van Der Zee, E. D. de Vries, G. T. te Meerman, 2005, International Journal of Gynecologic Cancer.

Identification of candidate epigenetic biomarkers for ovarian cancer detection.

Robert Brown, S. Liyanarachchi, K. Nephew, 2009, Oncology reports.

Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia

Ritsert C. Jansen, Frank Johannes, Ed Schuuring, 2012, Epigenetics.

Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant.

H. Hollema, A. V. D. Van Der Zee, E. D. de Vries, 2002, American journal of human genetics.

Lack of telomerase RNA gene hTERC expression in alternative lengthening of telomeres cells is associated with methylation of the hTERC promoter.

A. V. D. Van Der Zee, W. Keith, J. Going, 2001, Cancer research.

Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer

M. Widschwendter, E. Schuuring, A. V. D. Van Der Zee, 2017, BMC Medicine.

Telomerase and Telomeres: From Basic Biology to Cancer Treatment

A. V. D. Van Der Zee, G. Wisman, M. Helder, 2002, Cancer investigation.

Potential Target Antigens for a Universal Vaccine in Epithelial Ovarian Cancer

H. Hollema, A. V. D. Van Der Zee, G. D. de Bock, 2010, Clinical & developmental immunology.

Sentinel node dissection is safe in the treatment of early-stage vulvar cancer.

Achim Schneider, A. V. D. Van Der Zee, A. Schneider, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breaking the DNA damage response to improve cervical cancer treatment.

A. V. D. Van Der Zee, E. D. de Vries, M. V. van Vugt, 2016, Cancer treatment reviews.

Integrated transcriptomic and epigenomic analysis of ovarian cancer reveals epigenetically silenced GULP1.

A. Zhavoronkov, A. Chatterjee, A. V. D. Van Der Zee, 2018, Cancer letters.

Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.

G. Giaccone, A. V. D. Van Der Zee, M. Flens, 1995, Journal of the National Cancer Institute.

Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma.

R. Bernards, A. V. D. Van Der Zee, S. de Jong, 2019, Cancer letters.

The role of ATM and 53BP1 as predictive markers in cervical cancer

H. Hollema, E. Schuuring, A. V. D. Van Der Zee, 2012, International journal of cancer.

Telomerase in (pre)neoplastic cervical disease.

H. Hollema, A. V. D. Van Der Zee, E. D. de Vries, 2000, Human pathology.

Safety of laparoscopy versus laparotomy in early-stage endometrial cancer: a randomised trial.

A. V. D. Van Der Zee, G. D. de Bock, W. Post, 2010, The Lancet. Oncology.

The epidermal growth factor receptor pathway in relation to pelvic lymph node metastasis and survival in early-stage cervical cancer.

H. Hollema, E. Schuuring, A. V. D. Van Der Zee, 2010, Human pathology.

Implementing an advanced laparoscopic procedure by monitoring with a visiting surgeon.

A. V. D. Van Der Zee, G. D. de Bock, M. Mourits, 2010, Journal of minimally invasive gynecology.

Human Papilloma Virus 16 E6 RNA Interference Enhances Cisplatin and Death Receptor-Mediated Apoptosis in Human Cervical Carcinoma Cells

A. V. D. Van Der Zee, E. D. de Vries, S. de Jong, 2012, Molecular Pharmacology.

Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.

A. V. D. Van Der Zee, E. D. de Vries, S. de Jong, 2005, Gynecologic oncology.

Multi‐parametric profiling of renal cell, colorectal, and ovarian cancer identifies tumour‐type‐specific stroma phenotypes and a novel vascular biomarker

A. V. D. Van Der Zee, K. Jirström, G. Wisman, 2017, The journal of pathology. Clinical research.

Clinical potential of inhibitors of survival pathways and activators of apoptotic pathways in treatment of cervical cancer: changing the apoptotic balance.

Elisabeth G E de Vries, A. V. D. Van Der Zee, E. D. de Vries, 2005, The Lancet. Oncology.

Analysis of human serum by liquid chromatography-mass spectrometry: improved sample preparation and data analysis.

R. Jansen, A. V. D. Van Der Zee, R. Bischoff, 2006, Journal of chromatography. A.

An Overview of Innovative Techniques to Improve Cervical Cancer Screening

H. Hollema, E. Schuuring, A. V. D. Van Der Zee, 2006, Cellular oncology : the official journal of the International Society for Cellular Oncology.

Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer.

H. Boezen, H. Hollema, A. V. D. Van Der Zee, 2009, Gynecologic oncology.

Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations.

H. Hollema, R. Hofstra, A. Zee, 1999, American journal of human genetics.

Sentinel lymph node identification with technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva.

H. Hollema, A. V. D. Van Der Zee, D. Piers, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Surgical Treatment of Early-Stage Cervical Cancer: A Multi-Institution Experience in 2124 Cases in The Netherlands Over a 30-Year Period

A. Zwinderman, G. Kenter, A. V. D. Van Der Zee, 2018, International Journal of Gynecologic Cancer.

Laparoscopic hysterectomy is preferred over laparotomy in early endometrial cancer patients, however not cost effective in the very obese.

A. V. D. Van Der Zee, K. Vermeulen, G. D. de Bock, 2011, European journal of cancer.

DNA methylation markers as triage test for the early identification of cervical lesions in a Chinese population

E. Schuuring, A. V. D. Van Der Zee, G. Wisman, 2020, International journal of cancer.

First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers

E. Schuuring, A. V. D. Van Der Zee, J. Kosterink, 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 gene

N. Rosenfeld, R. Bernards, M. Jimenez-Linan, 2020, PloS one.

DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort

M. Poljak, E. Schuuring, A. V. D. Van Der Zee, 2018, International journal of cancer.

Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3

H. Hollema, E. Schuuring, A. V. D. Van Der Zee, 2016, Clinical Epigenetics.

Comparing the Cervista HPV HR Test and Hybrid Capture 2 Assay in a Dutch Screening Population: Improved Specificity of the Cervista HPV HR Test by Changing the Cut-Off

E. Schuuring, A. V. D. Van Der Zee, H. Klip, 2014, PloS one.

A four‐gene methylation marker panel as triage test in high‐risk human papillomavirus positive patients

H. Hollema, E. Schuuring, A. V. D. Van Der Zee, 2012, International journal of cancer.

Detection of cervical neoplasia by DNA methylation analysis in cervico-vaginal lavages, a feasibility study.

E. Schuuring, A. V. D. Van Der Zee, H. Klip, 2011, Gynecologic oncology.

Methylation Markers for CCNA1 and C13ORF18 Are Strongly Associated with High-Grade Cervical Intraepithelial Neoplasia and Cervical Cancer in Cervical Scrapings

E. Schuuring, A. V. D. Van Der Zee, H. Klip, 2009, Cancer Epidemiology, Biomarkers & Prevention.

Cost effectiveness of laparoscopy versus laparotomy in early stage endometrial cancer: a randomised trial.

Geertruida H de Bock, A. V. D. Van Der Zee, K. Vermeulen, 2011, Gynecologic oncology.

Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study.

Yoram Cohen, David Sidransky, H. Boezen, 2004, Molecular cancer research : MCR.

Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis

A. V. D. Van Der Zee, E. D. de Vries, S. de Jong, 2011, British Journal of Cancer.

Serum Cytokine Profiling as a Diagnostic and Prognostic Tool in Ovarian Cancer: A Potential Role for Interleukin 7

A. V. D. Van Der Zee, A. Crijns, W. Sluiter, 2007, Clinical Cancer Research.

Involvement of the TGF-β and β-Catenin Pathways in Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer

H. Hollema, E. Schuuring, A. V. D. Van Der Zee, 2011, Clinical Cancer Research.

Molecular analysis of the topoisomerase II alpha gene and its expression in human ovarian cancer.

H. Hollema, A. V. D. Van Der Zee, R. Brown, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies.

M. von Knebel Doeberitz, M. Blettner, A. Giuliano, 2009, The Lancet. Oncology.

Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia

H. Boezen, H. Hollema, E. Schuuring, 2003, Journal of clinical pathology.

An SV40 large T-antigen immortalized human umbilical vein endothelial cell line for anti-endothelial cell antibody detection.

R. van Wijk, A. V. D. Van Der Zee, G. Molema, 2001, Clinical and experimental rheumatology.

Normal T-cell telomerase activity and upregulation in human immunodeficiency virus-1 infection.

A. Zee, A. V. D. Van Der Zee, F. Miedema, 1999, Blood.

Enhanced Antitumor Efficacy of a DR5-Specific TRAIL Variant over Recombinant Human TRAIL in a Bioluminescent Ovarian Cancer Xenograft Model

H. Hollema, A. V. D. Van Der Zee, E. D. de Vries, 2009, Clinical Cancer Research.

HLA class I alleles and cervical neoplasia.

A. V. D. Van Der Zee, H. Klip, T. Daemen, 2003, The Journal of infectious diseases.

Re: Terada et al.: Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva. Gynecol Oncol 76:40-44, 2000.

A. V. D. Van Der Zee, R. Coleman, A. Ansink, 2000, Gynecologic Oncology.

Cell biological markers of drug resistance in ovarian carcinoma.

H. Hollema, H. D. de Bruijn, A. V. D. Van Der Zee, 1995, Gynecologic oncology.

Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas.

H. Hollema, A. V. D. Van Der Zee, E. D. de Vries, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.

H. Hollema, A. V. D. Van Der Zee, E. D. de Vries, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.

Ignace Vergote, Andreas Scorilas, Marco Massobrio, 2003, Cancer research.

Turning promise into progress for antiangiogenic agents in epithelial ovarian cancer.

A. V. D. Van Der Zee, E. D. de Vries, S. de Jong, 2012, Critical reviews in oncology/hematology.

Measurement of Tumor VEGF-A Levels with 89Zr-Bevacizumab PET as an Early Biomarker for the Antiangiogenic Effect of Everolimus Treatment in an Ovarian Cancer Xenograft Model

A. V. D. Van Der Zee, E. D. de Vries, S. de Jong, 2012, Clinical Cancer Research.

Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer

E. Schuuring, C. Meijer, P. Snijders, 2018, Epigenetics.

Methylenetetrahydrofolate reductase (MTHFR) and susceptibility for (pre)neoplastic cervical disease

A. V. D. Van Der Zee, E. D. de Vries, G. T. te Meerman, 2005, Human Genetics.

Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer.

Daniel W Chan, Yinhua Yu, R. Bast, 2007, Gynecologic oncology.

Enhancement of human papilloma virus type 16 E7 specific T cell responses by local invasive procedures in patients with (pre)malignant cervical neoplasia

E. Schuuring, A. V. D. Van Der Zee, F. Miedema, 2006, International journal of cancer.

Superior Therapeutic Efficacy of Alphavirus-Mediated Immunization against Human Papilloma Virus Type 16 Antigens in a Murine Tumour Model: Effects of the Route of Immunization

A. V. D. Van Der Zee, B. Dontje, J. Wilschut, 2004, Antiviral therapy.

Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancer.

H. Boezen, H. Hollema, A. V. D. Van Der Zee, 2009, Gynecologic oncology.

Is aromatase cytochrome P450 involved in the pathogenesis of endometrioid endometrial cancer?

H. Hollema, A. V. D. Van Der Zee, M. Heineman, 2005, International Journal of Gynecologic Cancer.

The importance of family history in young patients with endometrial cancer.

H. Hollema, A. Zee, A. V. D. Van Der Zee, 1999, European journal of obstetrics, gynecology, and reproductive biology.

Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer.

H. Hollema, A. V. D. Van Der Zee, S. de Jong, 2014, Gynecologic oncology.

Prognostic cell biological markers in cervical cancer patients primarily treated with (chemo)radiation: a systematic review.

E. Schuuring, A. V. D. Van Der Zee, G. Wisman, 2011, International journal of radiation oncology, biology, physics.

Germline mutations of EXO1 gene in patients with hereditary nonpolyposis colorectal cancer (HNPCC) and atypical HNPCC forms.

H. Hollema, R. Hofstra, A. V. D. Van Der Zee, 2001, Gastroenterology.

Loss of MSH2 protein expression is a risk factor in early stage cervical cancer

H. Boezen, H. Hollema, A. V. D. Van Der Zee, 2006, Journal of Clinical Pathology.

Influence of clotting time on the protein composition of serum samples based on LC-MS data.

A. V. D. Van Der Zee, R. Bischoff, P. Horvatovich, 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Prolonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugs

M. Rots, K. Kok, E. Schuuring, 2015, Epigenetics.

Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.

H. Hollema, H. D. de Bruijn, A. V. D. Van Der Zee, 2000, Gynecologic oncology.

Multiple Testing Issues in Discriminating Compound-Related Peaks and Chromatograms from High Frequency Noise, Spikes and Solvent-Based Noise in LC - MS Data Sets

R. Jansen, A. V. D. Van Der Zee, A. V. van Kampen, 2007, Statistical applications in genetics and molecular biology.

Higher levels of interleukin‐6 in cystic fluids from patients with malignant versus benign ovarian tumors correlate with decreased hemoglobin levels and increased platelet counts

H. D. de Bruijn, A. V. D. Van Der Zee, E. D. de Vries, 1995, Cancer.

Nuclear COMMD1 Is Associated with Cisplatin Sensitivity in Ovarian Cancer

A. V. D. Van Der Zee, M. V. van Vugt, B. van de Sluis, 2016, PloS one.

Routine follow-up intervals in patients with high-grade squamous intraepithelial lesions (HSIL) and free excision margins can safely be increased in the first two years after Large Loop Excision of the Transformation Zone (LLETZ).

H. Hollema, A. V. D. Van Der Zee, G. D. de Bock, 2009, Gynecologic oncology.

Identification of Analytical Factors Affecting Complex Proteomics Profiles Acquired in a Factorial Design Study with Analysis of Variance: Simultaneous Component Analysis.

A. Smilde, H. Hoefsloot, F. Suits, 2016, Analytical chemistry.

ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors

R. Bernards, T. Severson, A. V. D. Van Der Zee, 2018, Oncogene.

A New Perspective on Transcriptional System Regulation (TSR): Towards TSR Profiling

Willem A. Kamps, Elisabeth G. E. de Vries, Rudolf S. N. Fehrmann, 2008, PloS one.

Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer.

H. Hollema, H. D. de Bruijn, A. V. D. Van Der Zee, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic impact of MAD1L1 promoter hypermethylation in advanced ovarian cancer.

S. Liyanarachchi, A. V. D. Van Der Zee, A. Crijns, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improved outcomes due to changes in organization of care for patients with ovarian cancer in the Netherlands.

W. van Driel, A. V. D. Van Der Zee, M. van der Aa, 2016, Gynecologic oncology.

Clinical Validation of the Cervista HPV HR Test According to the International Guidelines for Human Papillomavirus Test Requirements for Cervical Cancer Screening

E. Schuuring, A. V. D. Van Der Zee, G. Wisman, 2014, Journal of Clinical Microbiology.

Serum and Cystic Fluid Levels of Soluble Interleukin-2 Receptor-Alpha in Patients with Epithelial Ovarian Tumors Are Correlated

H. D. de Bruijn, A. V. D. Van Der Zee, K. T. ten Hoor, 1998, Tumor Biology.

[Preservation of ovarian function in 2 young women with Hodgkin disease by laparoscopic transposition of the ovaries prior to abdominal irradiation].

A. V. D. Van Der Zee, R. Tamminga, W. Dolsma, 1999, Nederlandsch tijdschrift voor geneeskunde.

Expression of Epidermal Growth Factor Receptor (EGFR) and Activated EGFR Predict Poor Response to (Chemo)radiation and Survival in Cervical Cancer

H. Hollema, E. Schuuring, A. V. D. Van Der Zee, 2009, Clinical Cancer Research.

Routine evaluation and treatment of unexplained menorrhagia: do we consider haemostatic disorders?

A. V. D. Van Der Zee, H. Kluin-Nelemans, K. Meijer, 2010, European journal of obstetrics, gynecology, and reproductive biology.

A large-scale multi-center independent validation study of a panel of seven biomarkers for the detection of ovarian cancer.

R. Bast, E. Fung, D. Chan, 2006, Journal of Clinical Oncology.

Discovery of DNA methylation markers in cervical cancer using relaxation ranking

E. Schuuring, A. V. D. Van Der Zee, G. Wisman, 2008, BMC Medical Genomics.

hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents

A. V. D. Van Der Zee, G. Margison, W. Gallagher, 1997, Oncogene.

Endodermal sinus tumor of the ovary during pregnancy: a case report.

H. D. de Bruijn, A. V. D. Van Der Zee, E. D. de Vries, 1991, American journal of obstetrics and gynecology.